These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 37991252)
1. Biomimetic Macrophage Membrane-Camouflaged Nanoparticles Induce Ferroptosis by Promoting Mitochondrial Damage in Glioblastoma. Cao Z; Liu X; Zhang W; Zhang K; Pan L; Zhu M; Qin H; Zou C; Wang W; Zhang C; He Y; Lin W; Zhang Y; Han D; Li M; Gu J ACS Nano; 2023 Dec; 17(23):23746-23760. PubMed ID: 37991252 [TBL] [Abstract][Full Text] [Related]
2. Synchronous Disintegration of Ferroptosis Defense Axis via Engineered Exosome-Conjugated Magnetic Nanoparticles for Glioblastoma Therapy. Li B; Chen X; Qiu W; Zhao R; Duan J; Zhang S; Pan Z; Zhao S; Guo Q; Qi Y; Wang W; Deng L; Ni S; Sang Y; Xue H; Liu H; Li G Adv Sci (Weinh); 2022 Jun; 9(17):e2105451. PubMed ID: 35508804 [TBL] [Abstract][Full Text] [Related]
3. Biomimetic Dp44mT-nanoparticles selectively induce apoptosis in Cu-loaded glioblastoma resulting in potent growth inhibition. Ismail M; Yang W; Li Y; Wang Y; He W; Wang J; Muhammad P; Chaston TB; Rehman FU; Zheng M; Lovejoy DB; Shi B Biomaterials; 2022 Oct; 289():121760. PubMed ID: 36044788 [TBL] [Abstract][Full Text] [Related]
4. Near Infrared-Activatable Biomimetic Nanoplatform for Tumor-Specific Drug Release, Penetration and Chemo-Photothermal Synergistic Therapy of Orthotopic Glioblastoma. Li M; Zhang X; Zhou Y; Chu Y; Shen J; Cai Y; Sun X Int J Nanomedicine; 2024; 19():6999-7014. PubMed ID: 39011386 [TBL] [Abstract][Full Text] [Related]
5. A Trojan-Horse-Like Biomimetic Nano-NK to Elicit an Immunostimulatory Tumor Microenvironment for Enhanced GBM Chemo-Immunotherapy. Zhang L; Zhang Y; Wang X; Zhou Y; Qi J; Gu L; Zhao Q; Yu R; Zhou X Small; 2023 Nov; 19(44):e2301439. PubMed ID: 37420326 [TBL] [Abstract][Full Text] [Related]
6. Fatostatin induces ferroptosis through inhibition of the AKT/mTORC1/GPX4 signaling pathway in glioblastoma. Cai J; Ye Z; Hu Y; Ye L; Gao L; Wang Y; Sun Q; Tong S; Zhang S; Wu L; Yang J; Chen Q Cell Death Dis; 2023 Mar; 14(3):211. PubMed ID: 36966152 [TBL] [Abstract][Full Text] [Related]
7. NIR-promoted ferrous ion regeneration enhances ferroptosis for glioblastoma treatment. Xue K; Yang R; An Y; Ding Y; Li S; Miao F; Liu D; Chen D; Tang Q J Control Release; 2024 Apr; 368():595-606. PubMed ID: 38185333 [TBL] [Abstract][Full Text] [Related]
9. A gain of function paradox: Targeted therapy for glioblastoma associated with abnormal NHE9 expression. Pall AE; Juratli L; Guntur D; Bandyopadhyay K; Kondapalli KC J Cell Mol Med; 2019 Nov; 23(11):7859-7872. PubMed ID: 31532058 [TBL] [Abstract][Full Text] [Related]
10. Brain-Targeted Codelivery of Bcl-2/Bcl-xl and Mcl-1 Inhibitors by Biomimetic Nanoparticles for Orthotopic Glioblastoma Therapy. He W; Li X; Morsch M; Ismail M; Liu Y; Rehman FU; Zhang D; Wang Y; Zheng M; Chung R; Zou Y; Shi B ACS Nano; 2022 Apr; 16(4):6293-6308. PubMed ID: 35353498 [TBL] [Abstract][Full Text] [Related]
11. Effective glioblastoma immune sonodynamic treatment mediated by macrophage cell membrane cloaked biomimetic nanomedicines. Shan T; Wang W; Fan M; Bi J; He T; Sun Y; Zheng M; Yan D J Control Release; 2024 Jun; 370():866-878. PubMed ID: 38685386 [TBL] [Abstract][Full Text] [Related]
12. Biomimetic GBM-targeted drug delivery system boosting ferroptosis for immunotherapy of orthotopic drug-resistant GBM. Liu B; Ji Q; Cheng Y; Liu M; Zhang B; Mei Q; Liu D; Zhou S J Nanobiotechnology; 2022 Mar; 20(1):161. PubMed ID: 35351131 [TBL] [Abstract][Full Text] [Related]
13. Cancer cell-mitochondria hybrid membrane coated Gboxin loaded nanomedicines for glioblastoma treatment. Zou Y; Sun Y; Wang Y; Zhang D; Yang H; Wang X; Zheng M; Shi B Nat Commun; 2023 Jul; 14(1):4557. PubMed ID: 37507371 [TBL] [Abstract][Full Text] [Related]
14. Stimuli-Responsive Multifunctional Nanomedicine for Enhanced Glioblastoma Chemotherapy Augments Multistage Blood-to-Brain Trafficking and Tumor Targeting. Martins C; Araújo M; Malfanti A; Pacheco C; Smith SJ; Ucakar B; Rahman R; Aylott JW; Préat V; Sarmento B Small; 2023 Jun; 19(22):e2300029. PubMed ID: 36852650 [TBL] [Abstract][Full Text] [Related]
15. CRISPR-Cas9 library screening combined with an exosome-targeted delivery system addresses tumorigenesis/TMZ resistance in the mesenchymal subtype of glioblastoma. Zhao J; Cui X; Zhan Q; Zhang K; Su D; Yang S; Hong B; Wang Q; Ju J; Cheng C; Li C; Wan C; Wang Y; Zhou J; Kang C Theranostics; 2024; 14(7):2835-2855. PubMed ID: 38773970 [No Abstract] [Full Text] [Related]
16. Inhibitory effects of temozolomide on glioma cells is sensitized by RSL3-induced ferroptosis but negatively correlated with expression of ferritin heavy chain 1 and ferritin light chain. Yang FC; Wang C; Zhu J; Gai QJ; Mao M; He J; Qin Y; Yao XX; Wang YX; Lu HM; Cao MF; He MM; Wen XM; Leng P; Cai XW; Yao XH; Bian XW; Wang Y Lab Invest; 2022 Jul; 102(7):741-752. PubMed ID: 35351965 [TBL] [Abstract][Full Text] [Related]
17. Allomelanin-based biomimetic nanotherapeutics for orthotopic glioblastoma targeted photothermal immunotherapy. Sun M; Li Y; Zhang W; Gu X; Wen R; Zhang K; Mao J; Huang C; Zhang X; Nie M; Zhang Z; Qi C; Cai K; Liu G Acta Biomater; 2023 Aug; 166():552-566. PubMed ID: 37236575 [TBL] [Abstract][Full Text] [Related]
18. Biomimetic calcium carbonate nanoparticles delivered IL-12 mRNA for targeted glioblastoma sono-immunotherapy by ultrasound-induced necroptosis. Zhao P; Tian Y; Lu Y; Zhang J; Tao A; Xiang G; Liu Y J Nanobiotechnology; 2022 Dec; 20(1):525. PubMed ID: 36496387 [TBL] [Abstract][Full Text] [Related]
19. Efficient Delivery of Lomitapide using Hybrid Membrane-Coated Tetrahedral DNA Nanostructures for Glioblastoma Therapy. Song M; Tian J; Wang L; Dong S; Fu K; Chen S; Liu C Adv Mater; 2024 Jun; 36(24):e2311760. PubMed ID: 38569065 [TBL] [Abstract][Full Text] [Related]
20. Glioblastoma Therapy Using Codelivery of Cisplatin and Glutathione Peroxidase Targeting siRNA from Iron Oxide Nanoparticles. Zhang Y; Fu X; Jia J; Wikerholmen T; Xi K; Kong Y; Wang J; Chen H; Ma Y; Li Z; Wang C; Qi Q; Thorsen F; Wang J; Cui J; Li X; Ni S ACS Appl Mater Interfaces; 2020 Sep; 12(39):43408-43421. PubMed ID: 32885649 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]